Equity Overview
Price & Market Data
Price: $0.80
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $0
Volume: 0
Details
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. Its lead product candidate is ONC010, a novel inhibitor of the deoxyribonucleic acid repair enzyme polynucleotide kinase 3'-phosphatase in a nanoparticle formulation based on the drug delivery technology. The company is headquartered in Calgary, Canada.